DNA vaccines against rotavirus infections
Plasmid DNA vaccines encoding for murine rotaviral proteins VP4, VP6, and VP7 were tested in adult BALB/c mice for their ability to induce immune responses and provide protection against rotavirus challenge. Serum antibodies were measured by virus neutralization and by ELISA. Cellular immunity was assessed by measuring cytotoxic T cell (CTL) responses. The vaccines were administered by inoculation into cells of the epidermis with an Accell gene gun (Auragen, Inc., Middleton, WI, USA). Each of the three vaccines elicited rotavirus-specific serum antibodies as measured by ELISA. Virus neutralizing antibodies were detected in mice receiving DNA vaccines encoding for VP4 and VP7, but not in those which received the plasmid encoding for VP6. Vaccines encoding for VP4, VP6, or VP7 generated virus-specific CTL responses in recipient mice. Efficacy of the vaccines was determined by challenge with homotypic rotaviruses. Each of the three vaccines was effective in protecting mice against infection after rotavirus (100 ID50) challenge. Significant reductions (p < 0.0002, analysis of variance) in viral excretion measured over a 9 day period were seen in mice receiving the DNA vaccines compared with mice that received control plasmids.
KeywordsRabies Virus Gold Bead Adult Mouse Model
Unable to display preview. Download preview PDF.
- 2.Both GW, Lockett LJ, Janardhana V, Edwards SJ, Bellamy AR, Graham FL, Prevec L, Andrew ME (1993) Protective immunity to rotavirus-induced diarrhea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc. Virology 193: 940–950PubMedCrossRefGoogle Scholar
- 4.Conner ME, Matson DO, Estes MK (1994) Rotavirus vaccines and vaccination potential. In: Ramig RF (ed) Rotaviruses. Current Topics in Microbiology and Immunology 185: 285–371Google Scholar
- 5.Dharakul T, Labbe M, Cohen J, Bellamy AR, Street JE, Mackow ER, Fiore L, Rott L, Greenberg HB (1991) Immunization with baculovirus-expressed recombinant rotavirus proteins VP1, VP4, VP6 and VP7 induce CD8 + T lymphocytes that mediate clearance of chronic rotavirus infection in SCID mice. J Virol 65: 5928–5932PubMedGoogle Scholar
- 6.Dormitzer P, Burns JW, Greenberg HB, Prevec L, Graham F, Boyle DB, Both G (1993) Vaccination of adult mice with recombinant viruses expressing a protective rotavirus VP7sc. Abstr. IXth Intl. Cong. Virology, W21-2, p43Google Scholar
- 13.Kapikian AZ, Flores J, Midthun K, Hoshino Y, Green KY, Gorziglia M, Nishikawa K, Chanock RM, Potash L, Perez-Schael I (1989) Strategies for the development of a rotavirus vaccine against infantile diarrhea with an update on clinical trials of rotavirus vaccine. Adv Exp Med Biol 257: 67–89PubMedCrossRefGoogle Scholar
- 17.Riepenhoff-Talty M, Dharakul R, Kowalski E, Sterman D, Ogra PL (1987) Rotavirus infection in mice: pathogenesis and immunity. Adv Exp Med Biol 216B: 1015–1023Google Scholar
- 18.Saif LJ, Jackwood DJ (1990) Enteric Virus Vaccines: Theoretical considerations, current status, and future approaches. In: Saif LJ, Theil KW (eds) Viral Diarrheal of Man and Animals. CRC Press, Boca Raton, pp 313–329Google Scholar
- 19.Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Feigner PI, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A, Hawe LA, Leander KR, Martinez D, Perry HC, Shiver JW, Montgomery DL, Liu MA (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745–1749PubMedCrossRefGoogle Scholar